AU2001272761A1 - Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products - Google Patents
Sulfonic acid derivatives of hydroxamic acids and their use as medicinal productsInfo
- Publication number
- AU2001272761A1 AU2001272761A1 AU2001272761A AU7276101A AU2001272761A1 AU 2001272761 A1 AU2001272761 A1 AU 2001272761A1 AU 2001272761 A AU2001272761 A AU 2001272761A AU 7276101 A AU7276101 A AU 7276101A AU 2001272761 A1 AU2001272761 A1 AU 2001272761A1
- Authority
- AU
- Australia
- Prior art keywords
- sulfonic acid
- acid derivatives
- medicinal products
- hydroxamic acids
- relates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002253 acid Substances 0.000 title abstract 4
- 150000003458 sulfonic acid derivatives Chemical class 0.000 title abstract 4
- 150000007513 acids Chemical class 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000002158 endotoxin Substances 0.000 abstract 2
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
- C07C309/09—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton
- C07C309/11—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton with the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
Abstract
The present invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More particularly, the present invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides (LPS). In addition, the present invention relates to a novel intermediate compound useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-219245 | 2000-07-19 | ||
JP2000219034 | 2000-07-19 | ||
JP2000-219034 | 2000-07-19 | ||
JP2000219245 | 2000-07-19 | ||
PCT/JP2001/006275 WO2002006214A1 (en) | 2000-07-19 | 2001-07-19 | Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001272761A1 true AU2001272761A1 (en) | 2002-01-30 |
Family
ID=26596313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001272761A Abandoned AU2001272761A1 (en) | 2000-07-19 | 2001-07-19 | Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
Country Status (9)
Country | Link |
---|---|
US (1) | US6989401B2 (en) |
EP (1) | EP1306367B1 (en) |
KR (1) | KR100799192B1 (en) |
CN (1) | CN1215052C (en) |
AT (1) | ATE367374T1 (en) |
AU (1) | AU2001272761A1 (en) |
CA (1) | CA2415954A1 (en) |
DE (1) | DE60129442T2 (en) |
WO (1) | WO2002006214A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005016455A2 (en) | 2003-08-14 | 2005-02-24 | D. Collen Research Foundation Vzw | Antibodies against factor viii with modified glycosylation in the variable region |
US7829085B2 (en) | 1999-07-14 | 2010-11-09 | Life Sciences Research Partners Vzw | Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII |
WO2004085396A1 (en) * | 2003-03-26 | 2004-10-07 | Mitsubishi Pharma Corporation | Preventive or therapeutic agent for ischemia/reperfusion injury, organ preservative, and screening method |
US20070010573A1 (en) * | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
JPWO2005037265A1 (en) * | 2003-10-17 | 2006-12-28 | 三菱ウェルファーマ株式会社 | Concomitant drugs |
JP2007515403A (en) * | 2003-11-17 | 2007-06-14 | ワイス | Method for preparing N-substituted phthalimide |
US8574863B2 (en) | 2004-02-04 | 2013-11-05 | Pharmaaware Sepsis B.V. | Alkaline phosphatase for treating an inflammatory disease of the gastro-intestinal tract |
AU2005326962A1 (en) | 2004-12-22 | 2006-08-17 | Bellus Health (International) Limited | Methods and compositions for treating amyloid-related diseases |
EA016568B1 (en) | 2006-10-12 | 2012-05-30 | Беллус Хелс (Интернэшнл) Лимитед | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
US9353061B2 (en) | 2012-07-20 | 2016-05-31 | Academia Sinica | 3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof |
KR102166110B1 (en) | 2014-01-24 | 2020-10-16 | 에이엠-파마 비.브이. | Chimeric alkaline phosphatase-like proteins |
ES2688066T3 (en) | 2014-01-24 | 2018-10-30 | Am-Pharma B.V. | Processing for recovery and purification of an alkaline phosphatase |
TW202320794A (en) * | 2017-02-28 | 2023-06-01 | 美商伊繆諾金公司 | Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
GB9102635D0 (en) | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
US5318964A (en) | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
GB9223904D0 (en) | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
CA2158352A1 (en) | 1993-03-16 | 1994-09-29 | Michael John Crimmin | Hydroxamic acid derivatives as metalloproteinase inhibitors |
JPH07157470A (en) | 1993-03-18 | 1995-06-20 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
DE69632821T2 (en) * | 1995-04-25 | 2005-08-25 | Daiichi Fine Chemical Co., Ltd., Takaoka | HIGHLY METALOPROTEINASE INHIBITOR IN WATER |
US6610729B1 (en) * | 1998-05-22 | 2003-08-26 | Mitsubishi Pharma Corporation | Hydroxamic acid derivatives and medicinal utilization thereof |
US6797505B2 (en) * | 1998-05-27 | 2004-09-28 | Cell Genesys, Inc. | Recombinant AAV vectors for gene therapy of hemophilia A |
-
2001
- 2001-07-19 CN CNB018130518A patent/CN1215052C/en not_active Expired - Fee Related
- 2001-07-19 CA CA002415954A patent/CA2415954A1/en not_active Abandoned
- 2001-07-19 KR KR1020037000808A patent/KR100799192B1/en not_active IP Right Cessation
- 2001-07-19 WO PCT/JP2001/006275 patent/WO2002006214A1/en active IP Right Grant
- 2001-07-19 AT AT01951935T patent/ATE367374T1/en not_active IP Right Cessation
- 2001-07-19 AU AU2001272761A patent/AU2001272761A1/en not_active Abandoned
- 2001-07-19 EP EP01951935A patent/EP1306367B1/en not_active Expired - Lifetime
- 2001-07-19 US US10/333,266 patent/US6989401B2/en not_active Expired - Fee Related
- 2001-07-19 DE DE60129442T patent/DE60129442T2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1215052C (en) | 2005-08-17 |
US20030176486A1 (en) | 2003-09-18 |
KR100799192B1 (en) | 2008-01-31 |
EP1306367A4 (en) | 2004-06-09 |
CN1443158A (en) | 2003-09-17 |
CA2415954A1 (en) | 2003-01-17 |
KR20030029628A (en) | 2003-04-14 |
EP1306367A1 (en) | 2003-05-02 |
DE60129442T2 (en) | 2008-04-17 |
US6989401B2 (en) | 2006-01-24 |
WO2002006214A1 (en) | 2002-01-24 |
DE60129442D1 (en) | 2007-08-30 |
ATE367374T1 (en) | 2007-08-15 |
EP1306367B1 (en) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69830504D1 (en) | ANTITROMOMBOTIC MEANS | |
ES2182852T3 (en) | PROLINAMIDE DERIVATIVES | |
AU2002211216A1 (en) | Substituted aminopropoxyaryl derivatives useful as agonists for lxr | |
WO2001019776A3 (en) | Novel derivatives of dicarboxylic acid having pharmaceutical properties | |
BR9905981A (en) | Isochromanic compounds and processes for their production. | |
ATE306261T1 (en) | ANTITHROMBOTIC AGENTS | |
EA200300065A1 (en) | OXIDIZED COMPLEX ETHERS OF 4-IODPHENYLAMINOBENE HYDROXAMIC ACIDS | |
AU2001272761A1 (en) | Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products | |
NO20024772D0 (en) | Percyquinnin, process for its preparation and its use as a drug | |
AU2055500A (en) | Aromatic amides | |
WO2002010154A3 (en) | Substituted heterocyclic amides | |
DK1004578T3 (en) | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives | |
MY123908A (en) | Meta-azacyclic amino benzoic acid compounds and derivatives thereof | |
CA2412047A1 (en) | Shortened synthesis of 3,3-diarylpropylamine derivatives | |
IL136100A (en) | Biphenylamidine derivatives and pharmaceutical compositions containing the same | |
DE60114640D1 (en) | Antithrombosemittel | |
PL377478A1 (en) | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
DK1180094T3 (en) | Condensed polycyclic amino acids as pharmaceuticals | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
WO2001083423A3 (en) | 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof | |
HUP0401895A2 (en) | N-formyl derivatives of paroxetine, process for their preparation and pharmaceutical compositions containing them | |
EP1306368A3 (en) | 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor | |
WO2003104189A3 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
AU2002359044A1 (en) | Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor | |
BG103923A (en) | Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence |